Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel H Fowler

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.
Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancerMichael R Bishop, Daniel H Fowler, Donna Marchigiani, et al.
Haematologica|June 20, 2015
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practiceLauren M Curtis, Manuel B Datiles, Seth M Steinberg, et al.
Experimental Hematology|January 30, 2007
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantationMatin M Imanguli, Jane C Atkinson, Kristen E Harvey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignanciesRachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
The Journal of Experimental Medicine|May 12, 2017
PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cellsSamuel Taylor, Yuefeng Huang, Grace Mallett, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Clinical and Translational Medicine|January 10, 2025
Lentivirus-mediated gene therapy for Fabry disease: 5-year End-of-Study results from the Canadian FACTs trialAneal Khan, Dwayne L Barber, William M McKillop, et al.
Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.
Plos Biology|February 4, 2010
Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, et al.
Plos One|March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesisCourtney A Granville, Regan M Memmott, Andria Balogh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2004
Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancerMichael R Bishop, Daniel H Fowler, Donna Marchigiani, et al.
Haematologica|June 20, 2015
Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practiceLauren M Curtis, Manuel B Datiles, Seth M Steinberg, et al.
Experimental Hematology|January 30, 2007
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantationMatin M Imanguli, Jane C Atkinson, Kristen E Harvey, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 11, 2009
Strategies to improve long-term outcome in stage IIIB inflammatory breast cancer: multimodality treatment including dose-intensive induction and high-dose chemotherapyClaude Sportès, Seth M Steinberg, David J Liewehr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2012
Dose-adjusted EPOCH-rituximab combined with fludarabine provides an effective bridge to reduced-intensity allogeneic hematopoietic stem-cell transplantation in patients with lymphoid malignanciesRachel B Salit, Daniel H Fowler, Wyndham H Wilson, et al.
The Journal of Experimental Medicine|May 12, 2017
PD-1 regulates KLRG1<sup>+</sup> group 2 innate lymphoid cellsSamuel Taylor, Yuefeng Huang, Grace Mallett, et al.
Pageof 10